Antibodies are our immune system’s most sophisticated weapon against diseases and represent highly promising, but difficult to source therapeutics against a wide range of conditions.

Memo Therapeutics’¬†unique platform technology can capture and bank complete antibody repertoires of individual humans (and animals). It enables extremely fast and cost-efficient discovery of highly relevant therapeutic antibody candidates, increasing probability of success in the subsequent clinical development.